Neboglamine (hydrochloride)
Neboglamine (CR-2249, XY-2401) hydrochloride is an orally active NMDA receptor glycine site positive modulator that can be used in schizophrenia research[1].
Product Specifications
CAS Number
[2759182-59-5]
Product Name Alternative
CR-2249 (hydrochloride) ; XY-2401 (hydrochloride)
UNSPSC
12352211
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/neboglamine-hydrochloride.html
Purity
97.02
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC(CC[C@H](N)C(NC1CCC(C)(CC1)C)=O)=O.Cl
Molecular Formula
C13H25ClN2O3
Molecular Weight
292.80
References & Citations
[1]Riccardo Chiusaroli, et al. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat. Pharmacol Res. 2010 May;61 (5) :430-6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NMDA Receptor
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV811554 1.0 µg DNA
FLJ10404 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details 
E33C100446B 100 µL
Biotinylated Anti-CD117 antibody (EN0C446), IgG1 Chimeric mAb
Sign In for Pricing
View Details